Similarly, circ-MAPK4 (259 bp), detected in clinical glioma samples, promotes tumor progression by preventing apoptosis through the suppression of caspase 3/7/9 activation and enhancing p38/MAPK signaling, thereby increasing glioma resistance to therapy [76]. This evidence concerns the gene MAPK4 and central nervous system cancer.